Internal Server Error

NorthStar Medical Radioisotopes - About the company

NorthStar Medical Radioisotopes is a series B company based in Madison (United States), founded in 2006 by George Messina. It operates as a Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. NorthStar Medical Radioisotopes has raised $15.1M in funding from Hendricks Holding and Stateline Angels. The company has 24 active competitors, including 6 funded and 4 that have exited. Its top competitors include companies like ARTMS, Curium and Alsachim.

Company Details

Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. Its patented technologies include innovative non-uranium-based molybdenum-99 production methods, a novel separation chemistry system, and tools for the nuclear medicine market. Products include Non-HEU 99-Molybdenum and RadioGenix intelligent isotope separation system. Claims to be the first domestic producer of 99-Molybdenum and the only supplier of Non-HEU material.
Key Metrics
Founded Year
2006
Location
Madison, United States
Stage
Series B
Total Funding
$15.1M in 16 rounds
Ranked
Employee Count
308 as on Mar 31, 2026
Similar Companies
Sign up to download NorthStar Medical Radioisotopes' company profile

NorthStar Medical Radioisotopes's funding and investors

NorthStar Medical Radioisotopes has raised a total funding of $15.1M over 16 rounds. Its first funding round was on Mar 11, 2010. Its latest funding round was a Grant (prize money) round on May 13, 2025 for $*****. 1 investor participated in its latest round. NorthStar Medical Radioisotopes has 6 institutional investors.

Here is the list of recent funding rounds of NorthStar Medical Radioisotopes:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 13, 2025
8202421
Grant (prize money)
2132076
8946903
3353028
3270182
Jul 23, 2019
4907822
Grant (prize money)
5797095
2344668
2772462
Apr 23, 2019
7485697
Conventional Debt
9233107
5528329
2609167
lockAccess funding benchmarks and valuations. Sign up today!

NorthStar Medical Radioisotopes' founders and board of directors

Founder? Claim Profile
The founders of NorthStar Medical Radioisotopes is George Messina.
Here are the details of NorthStar Medical Radioisotopes' key team members:

NorthStar Medical Radioisotopes' employee count trend

NorthStar Medical Radioisotopes has 308 employees as of Mar 26. Here is NorthStar Medical Radioisotopes's employee count trend over the years:
Employee count trend for NorthStar Medical Radioisotopes
lockUncover NorthStar Medical Radioisotopes' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

NorthStar Medical Radioisotopes's Competitors and alternates

Top competitors of NorthStar Medical Radioisotopes include ARTMS, Curium and Alsachim. Here is the list of Top 10 competitors of NorthStar Medical Radioisotopes, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
$15.1M
57/100
2nd
Logo for ARTMS
ARTMS
2013, Vancouver (Canada), Acquired
Provider and developer of radioisotope technologies
$26.6M
57/100
3rd
Logo for Curium
Curium
2017, Paris (France), Seed
Specialty developer, manufacturer & distributor of radiopharmaceuticals
-
56/100
4th
Logo for Alsachim
Alsachim
2005, Illkirch Graffenstaden (France), Acquired
Custom synthesis of stable radioisotopes & analytical services for pharmaceutical and biotech companies
-
42/100
5th
Logo for ATOMIC ALCHEMY
ATOMIC ALCHEMY
2017, Idaho Falls (United States), Acquired
Limited information available
$150K
40/100
6th
Logo for AZI
AZI
2017, Bunker Hill (United States), Series C
Developer of radiopharmaceuticals for imaging purposes
$58.3M
-
39/100
7th
Logo for Cassia
Cassia
2005, San Diego (United States), Unfunded
Isotope labelling services for biomolecules
-
-
37/100
8th
Biomedical company developing proprietary new chemistry for the synthesis of pharmaceutical compounds
-
36/100
9th
Logo for CellBion
CellBion
2010, Seoul (South Korea), Public
Radioactive probes for imaging
-
33/100
10th
Logo for Am Chemicals
Am Chemicals
2003, Oceanside (United States), Unfunded
Oligonucleotide synthesis solutions: solid supports, reagents, and expert services
-
-
33/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on NorthStar Medical Radioisotopes's competitors? Click here to see the top ones

NorthStar Medical Radioisotopes's Investments and acquisitions

NorthStar Medical Radioisotopes has made no investments or acquisitions yet.

News related to NorthStar Medical Radioisotopes

lockFilter this list
Media has covered NorthStar Medical Radioisotopes for a total of 10 events in the last 1 year, 4 of them have been about people movement and 2 about company updates.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about NorthStar Medical Radioisotopes

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford